FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083214 [Registered on: 24/03/2025] Trial Registered Prospectively
Last Modified On: 23/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Role of masooradi lepa on mukhdushika  
Scientific Title of Study   Randomized Controlled Clinical Trial To Study The Effect Of Masooradi Lepa In Mukhdushika With Special Referance To Acne Vulgaris 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Swati Harendra Rahangdale 
Designation  PG Scholar Swasthvritta 
Affiliation  LRP Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur 
Address  opd no. 1 Lokanete Rajarambapu Patil Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur, Tal - Walwa Dist Sangli 415409

Sangli
MAHARASHTRA
415409
India 
Phone  9075104841  
Fax    
Email  swatirahangdale.cm@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shweta Nakil 
Designation  Professor 
Affiliation  LRP Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur 
Address  opd no 1 Lokanete Rajarambapu Patil Ayurved Medical College and Hospital Post Graduate and Institute and Reseach centre Islampur Tal Walwa Dist Sangli 415409

Sangli
MAHARASHTRA
415409
India 
Phone  9850920891  
Fax    
Email  shwetanakil@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Swati Harendra Rahangdale 
Designation  PG Scholar Swasthvritta 
Affiliation  LRP Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur 
Address  opd no. 1 Lokanete Rajarambapu Patil Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur, Tal - Walwa Dist Sangli 415409

Sangli
MAHARASHTRA
415409
India 
Phone  9075104841  
Fax    
Email  swatirahangdale.cm@gmail.com  
 
Source of Monetary or Material Support  
opd no. 1 Lokanete Rajarambapu Patil Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur, Tal - Walwa Dist Sangli 415409 
 
Primary Sponsor  
Name  LRP Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur 
Address  opd no. 1 Lokanete Rajarambapu Patil Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur, Tal - Walwa Dist Sangli 415409 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Swati Harendra Rahangdale  LRP Ayurveda Hospital, Islampur  opd no.1 Lokanete Rajarambapu Patil Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur, Tal - Walwa Dist Sangli 415409
Sangli
MAHARASHTRA 
9075104841

swatirahangdale.cm@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
LOKNETE RAJARAMBAPU PATIL A YURVEDIC MEDICAL COLLEGE, HOSPITAL, POST GRADUATE INSTITUTE AND RESEARCH CENTER, ISLAMPUR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L089||Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: YUVANAPIDAKA (MUKHADUSHIKA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-lepa, लेप (Procedure Reference: Angadi Ravindra, Text book of Bhaishajya kalpana vijnana, 2d edition, Varanasi, Chaukhamba Surbharti prakashan 2016, Procedure details: The selected freshly dried drugs are taken in a clean Khalva yantra, pounded to fine powder form & filtered. This filtrate is again taken in Khalva yantra and added with required little quantity of water or any of the specified liquid preparations. The mixture is thoroughly triturated to obtain it in paste)
(1) Medicine Name: Lodradi Choorna, Reference: Susrut samhita chikitsasthan 20/37, Route: Topical, Dosage Form: Lepa Churna, Dose: 15(g), Frequency: od, Duration: 1 Weeks
2Intervention ArmProcedure-lepa, लेप (Procedure Reference: Shri Bramhanand shastri, yogratnakar uttarardh, chaukhamba shanshkrit sansthan varanashi, Edition 8, 2014, slock14, chapter 40, page 283, Procedure details: Take choorna of Masoordal & add milk to form paste & then add ghrit to apply lepa on face. It will be prescribed for 7 days after which face will become clean just like a Kamal Patra)
(1) Medicine Name: Masooradi Choorna, Reference: Yog Ratnakar 40/14, Route: Topical, Dosage Form: Lepa Churna, Dose: 18(g), Frequency: od, Duration: 1 Weeks
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  Individuals having symtomsof Mukhdushika will be included.
Individuals between age group of 12 to 30 Years Will be included.
Individuals will be selected of both sexes irrespective of
Socioeconomic Status. Patients who reported mild-to-moderate inflamed acne with lesion size
1 cm.
Reliable and cooperative patients able to followall study procedures
 
 
ExclusionCriteria 
Details  Individuals suffering from skin disorders other than
Mukhdushika.
Individuals suffering from any other systemic diseases will be excluded.Individuas prone to allergic reaction.Individual taking long term medication like oral contraceptive pills will be excluded.
Patients using facial topical medicine or receiving
any hormone therapy. Patients who have any facial skin disease (apart from acne vulgaris) such as psoriasis or eczema that may interfere with the study procedures.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Masooradi Lepa is Effective on Mukhdushika  15 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Lodhradi Lepa is Effective on Mukhdushika  15 Days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  04/04/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Regardless of wide research , detail understanding and treatment modalities it still remains to be cause of concern due to its recurrent nature. In this study of Randomised clinical trial  of Masooradi Lepa on Mukhdushika with special reference to Lodhradi lepa . 60 patient will be taken divided by 2 equal groups .One group will be given Masooradi Lepa  while other will be given Lodhradi and further research will be concluded.  
Close